Implanet receives FDA, CE Mark approval for JAZZ Lock — 3 insights

Bordeaux, France-based Implanet received FDA clearance and CE mark for its Jazz Lock implant.

Advertisement

Here are three insights:

 

1. The Jazz Lock is designed for degenerative spinal disorder surgery.

 

2. The implant is based on the polyester sublaminar braid platform.

 

3. With this implant, the JAZZ technological platform extends to the cervical spine.

 

“A result of collaboration with leading surgeons, Jazz Lock represents a major breakthrough: an innovative IP protected design offering surgeons a fusion device that no other company currently can,” said Régis Le Couedic, product development and manufacturing director, Implanet.

 

More articles on devices:
InVivo Therapeutics adds UVA Health System as INSPIRE study site: 4 takeaways
Anika Therapeutics names CMO, COO: 4 points
CareCredit, DePuy Synthes Mitek Sports Medicine form agreement — 3 highlights

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.